|
112
|
327
|
2qc6A |
Protein kinase ck2 in complex with dbc |
|
93
|
294
|
2qocA |
Human epha3 kinase domain, phosphorylated, amp-pnp bound structure |
|
113
|
327
|
2pvjA |
Structure-based design of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase ck2 |
|
88
|
310
|
2qokA |
Human epha3 kinase and juxtamembrane region, y596f:y602f:s768a triple mutant |
|
69
|
296
|
2qkrA |
Cryptosporidium parvum cyclin-dependent kinase cgd5_2510 with indirubin 3'-monoxime bound |
|
84
|
285
|
2qg5A |
Cryptosporidium parvum calcium dependent protein kinase cgd7_1840 |
|
90
|
310
|
2qo7A |
Human epha3 kinase and juxtamembrane region, dephosphorylated, amp-pnp bound |
|
110
|
328
|
2pvhA |
Structure-based design of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase ck2 |
|
97
|
324
|
2qnjA |
Kinase and ubiquitin-associated domains of mark3/par-1 |
|
83
|
286
|
2pe1A |
Crystal structure of human phosphoinositide-dependent protein kinase 1 (pdk1) {2-oxo-3-[1-(1h-pyrrol-2-yl)-eth-(z)-ylidene]-2,3-dihydro-1h-indol-5-yl}-urea {bx-517} complex |
|
150
|
612
|
2ozoA |
Autoinhibited intact human zap-70 |
|
95
|
294
|
2q0nA |
Structure of human p21 activating kinase 4 (pak4) in complex with a consensus peptide |
|
93
|
299
|
2py3A |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic e565g mutation responsible for pfeiffer syndrome |
|
114
|
328
|
2pvkA |
Structure-based design of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase ck2 |
|
93
|
348
|
2pmnX |
Crystal structure of pfpk7 in complex with an atp-site inhibitor |
|
99
|
311
|
2p2hA |
Crystal structure of the vegfr2 kinase domain in complex with a pyridinyl-triazine inhibitor |
|
119
|
446
|
2ptkA |
Chicken src tyrosine kinase |
|
90
|
298
|
2q0bA |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic e565a mutation responsible for pfeiffer syndrome |
|
92
|
299
|
2pz5A |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic n549t mutation responsible for pfeiffer syndrome |
|
84
|
277
|
2phkA |
The crystal structure of a phosphorylase kinase peptide substrate complex: kinase substrate recognition |
|
92
|
299
|
2pzpA |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic k526e mutation responsible for crouzon syndrome |
|
111
|
328
|
2pvrA |
Crystal structure of the catalytic subunit of protein kinase ck2 (c-terminal deletion mutant 1-335) in complex with two sulfate ions |
|
89
|
298
|
2psqA |
Crystal structure of unphosphorylated unactivated wild type fgf receptor 2 (fgfr2) kinase domain |
|
86
|
286
|
2pe0A |
Crystal structure of human phosphoinositide-dependent protein kinase 1 (pdk1) 5-hydroxy-3-[1-(1h-pyrrol-2-yl)-eth-(z)-ylidene]-1,3-dihydro-indol-2-one complex |
|
86
|
298
|
2pzrA |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic k641r mutation responsible for pfeiffer syndrome |
|
112
|
328
|
2pvmA |
Structure-based design of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase ck2 |
|
73
|
284
|
2pmiA |
Structure of the pho85-pho80 cdk-cyclin complex of the phosphate-responsive signal transduction pathway with bound atp-gamma-s |
|
75
|
287
|
2p0cA |
Catalytic domain of the proto-oncogene tyrosine-protein kinase mer |
|
71
|
295
|
2pk9A |
Structure of the pho85-pho80 cdk-cyclin complex of the phosphate-responsive signal transduction pathway |
|
82
|
322
|
2p55A |
X-ray structure of the human mitogen-activated protein kinase kinase 1 (mek1) in a complex with ligand and mgatp |
|
77
|
268
|
2pl0A |
Lck bound to imatinib |
|
82
|
286
|
2pe2A |
Crystal structure of human phosphoinositide-dependent protein kinase 1 (pdk1) 3-{5-[2-oxo-5-ureido-1,2-dihydro-indol-(3z)-ylidenemethyl]-1h-pyrrol-3-yl}-n-(2-piperidin-1-yl-ethyl)-benzamide complex |
|
101
|
356
|
2p33A |
Synthesis and sar of aminopyrimidines as novel c-jun n-terminal kinase (jnk) inhibitors |
|
85
|
348
|
2ozaB |
Structure of p38alpha complex |
|
91
|
348
|
2pmlX |
Crystal structure of pfpk7 in complex with an atp analogue |
|
57
|
320
|
2p3gX |
Crystal structure of a pyrrolopyridine inhibitor bound to mapkap kinase-2 |
|
94
|
312
|
2p2iA |
Crystal structure of the vegfr2 kinase domain in complex with a nicotinamide inhibitor |
|
88
|
348
|
2pmoX |
Crystal structure of pfpk7 in complex with hymenialdisine |
|
74
|
280
|
2p4iA |
Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine tie-2 kinase inhibitor |
|
93
|
340
|
2ozaA |
Structure of p38alpha complex |
|
82
|
292
|
2ou7A |
Structure of the catalytic domain of human polo-like kinase 1 |
|
104
|
349
|
2okrA |
Crystal structure of the p38a-mapkap kinase 2 heterodimer |
|
113
|
336
|
2ojfE |
Crystal structure of protein kinase a in complex with pyridine-pyrazolopyridine based inhibitors |
|
80
|
274
|
2o63A |
Crystal structure of pim1 with myricetin |
|
86
|
351
|
2ow3A |
Glycogen synthase kinase-3 beta in complex with bis-(indole)maleimide pyridinophane inhibitor |
|
84
|
282
|
2oo8X |
Synthesis, structural analysis, and sar studies of triazine derivatives as potent, selective tie-2 inhibitors |
|
93
|
303
|
2oj9A |
Structure of igf-1r kinase domain complexed with a benzimidazole inhibitor |
|
107
|
336
|
2oh0E |
Crystal structure of protein kinase a in complex with pyridine-pyrazolopyridine based inhibitors |
|
89
|
271
|
2of4A |
Crystal structure of furanopyrimidine 1 bound to lck |
|
98
|
325
|
2oxxA |
Protein kinase ck2 in complex with tetrabromobenzoimidazole derivatives k17, k22 and k32 |
